Literature DB >> 18641341

Deletion of flagellin's hypervariable region abrogates antibody-mediated neutralization and systemic activation of TLR5-dependent immunity.

Clément Nempont1, Delphine Cayet, Martin Rumbo, Coralie Bompard, Vincent Villeret, Jean-Claude Sirard.   

Abstract

TLRs trigger immunity by detecting microbe-associated molecular patterns (MAMPs). Flagellin is a unique MAMP because it harbors 1) an antigenic hypervariable region and 2) a conserved domain involved in TLR5-dependent systemic and mucosal proinflammatory and adjuvant activities. In this study, the contribution of the flagellin domains in TLR5 activation was investigated. We showed that TLR5 signaling can be neutralized in vivo by flagellin-specific Abs, which target the conserved domain. However, deletions of flagellin's hypervariable region abrogated the protein's intrinsic ability to trigger the production of neutralizing Abs. The fact that MAMP-specific Abs block TLR-mediated responses shows that this type of neutralization is a novel mechanism for down-regulating innate immunity. The stimulation of mucosal innate immunity and adjuvancy to foreign Ag was not altered by the hypervariable domain deletions. In contrast, this domain is essential to trigger systemic innate immunity, suggesting that there are distinct mechanisms for TLR5 activation in systemic and mucosal compartments. In summary, specific MAMP determinants control the production of neutralizing Abs and the compartmentalization of innate responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641341     DOI: 10.4049/jimmunol.181.3.2036

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  Enhanced antigen processing of flagellin fusion proteins promotes the antigen-specific CD8+ T cell response independently of TLR5 and MyD88.

Authors:  John T Bates; Aaron H Graff; James P Phipps; Jason M Grayson; Steven B Mizel
Journal:  J Immunol       Date:  2011-04-22       Impact factor: 5.422

2.  Enhanced influenza virus-like particle vaccines containing the extracellular domain of matrix protein 2 and a Toll-like receptor ligand.

Authors:  Bao-Zhong Wang; Harvinder S Gill; Sang-Moo Kang; Li Wang; Ying-Chun Wang; Elena V Vassilieva; Richard W Compans
Journal:  Clin Vaccine Immunol       Date:  2012-05-30

3.  Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection.

Authors:  Natalia Muñoz; Laurye Van Maele; Juan M Marqués; Analía Rial; Jean-Claude Sirard; José A Chabalgoity
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

4.  Boosting the IL-22 response using flagellin prevents bacterial infection in cigarette smoke-exposed mice.

Authors:  B Koné; M Pérez-Cruz; R Porte; F Hennegrave; C Carnoy; P Gosset; F Trottein; J-C Sirard; M Pichavant; P Gosset
Journal:  Clin Exp Immunol       Date:  2020-05-17       Impact factor: 4.330

Review 5.  Materials engineering for immunomodulation.

Authors:  Jeffrey A Hubbell; Susan N Thomas; Melody A Swartz
Journal:  Nature       Date:  2009-11-26       Impact factor: 49.962

6.  A repertoire of high-affinity monoclonal antibodies specific to S. typhi: as potential candidate for improved typhoid diagnostic.

Authors:  Chandresh Sharma; Anurag Sankhyan; Tarang Sharma; Naeem Khan; Susmita Chaudhuri; Niraj Kumar; Shinjini Bhatnagar; Navin Khanna; Ashutosh Tiwari
Journal:  Immunol Res       Date:  2015-07       Impact factor: 2.829

7.  Characterization of structural and immunological properties of a fusion protein between flagellin from Salmonella and lumazine synthase from Brucella.

Authors:  Y Hiriart; A H Rossi; M E Biedma; A J Errea; G Moreno; D Cayet; J Rinaldi; B Blancá; J C Sirard; F Goldbaum; P Berguer; M Rumbo
Journal:  Protein Sci       Date:  2017-03-16       Impact factor: 6.725

8.  Flagellin-Mediated Protection against Intestinal Yersinia pseudotuberculosis Infection Does Not Require Interleukin-22.

Authors:  Rémi Porte; Laurye Van Maele; Natalia Muñoz-Wolf; Benoit Foligné; Laure Dumoutier; Julien Tabareau; Delphine Cayet; Pierre Gosset; Nicolas Jonckheere; Isabelle Van Seuningen; José A Chabalgoity; Michel Simonet; Mohamed Lamkanfi; Jean-Christophe Renauld; Jean-Claude Sirard; Christophe Carnoy
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

9.  Antigen replacement of domains D2 and D3 in flagellin promotes mucosal IgA production and attenuates flagellin-induced inflammatory response after intranasal immunization.

Authors:  Jingyi Yang; Maohua Zhong; Yan Zhang; Ejuan Zhang; Ying Sun; Yuan Cao; Yaoming Li; Dihan Zhou; Benxia He; Yaoqing Chen; Yi Yang; Jie Yu; Huimin Yan
Journal:  Hum Vaccin Immunother       Date:  2013-02-01       Impact factor: 3.452

10.  Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection.

Authors:  Bao-Zhong Wang; Rui Xu; Fu-Shi Quan; Sang-Moo Kang; Li Wang; Richard W Compans
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.